{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:58:39Z","timestamp":1781657919986,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.contraception.2011.03.012","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T17:48:13Z","timestamp":1304790493000},"page":"628-633","source":"Crossref","is-referenced-by-count":11,"title":["A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion"],"prefix":"10.1016","volume":"84","author":[{"given":"Vivian Chi Yan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oi Shan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Shu Biu","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak Chung","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.03.012_bb0005","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2005","volume":"57","author":"Gamble","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.contraception.2011.03.012_bb0010","series-title":"Statistical Bulletin 2008\/1","article-title":"Abortion statistics, England and Wales: 2008","author":"Department of Health","year":"2008"},{"key":"10.1016\/j.contraception.2011.03.012_bb0015","series-title":"The care of women requesting induced abortion","author":"Royal College of Obstetricians and Gynaecologists","year":"2004"},{"key":"10.1016\/j.contraception.2011.03.012_bb0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1999.tb08371.x","article-title":"Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases","volume":"106","author":"Ashok","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/den425","article-title":"A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion","volume":"24","author":"Chai","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.012_bb0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/15.3.709","article-title":"A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial","volume":"15","author":"Wong","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.012_bb0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2005.03.057","article-title":"Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens","volume":"193","author":"Edwards","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage: effect on uterine contractility and early pregnancy","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.012_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1479-828X.2009.01117.x","article-title":"Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort","volume":"50","author":"Dickinson","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.contraception.2011.03.012_bb0055","first-page":"1","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","author":"Gibson","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2011.03.012_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0960-0760(95)00045-2","article-title":"Arimidex\u2122: a new oral, once-a-day aromatase inhibitor","volume":"53","author":"Plourde","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.annonc.a010490","article-title":"Letrozole, a new oral non-steroidal aromatase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study","volume":"7","author":"Bisagni","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0070","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1023\/A:1008388823113","article-title":"Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors","volume":"11","author":"Bajetta","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0075","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/jm00173a001","article-title":"Mechanism and inhibition of cytochrome P-450 aromatase","volume":"33","author":"Cole","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.contraception.2011.03.012_bb0080","first-page":"244","article-title":"Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovary syndrome","volume":"10","author":"Mitwally","year":"2001","journal-title":"Reprod Technol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","article-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","volume":"83","author":"Mitwally","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.03.012_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0015-0282(01)03280-0","article-title":"Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders","volume":"77","author":"Mitwally","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.03.012_bb0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1472-6483(10)61046-2","article-title":"Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility","volume":"14","author":"Badawy","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.contraception.2011.03.012_bb0100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.012_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.03.012_bb0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0002-9378(00)70235-3","article-title":"The role of estrogen in the maintenance of primate pregnancy","volume":"182","author":"Albrecht","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.012_bb0115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.steroids.2003.09.002","article-title":"Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy","volume":"68","author":"Shi","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2011.03.012_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.contraception.2010.05.014","article-title":"A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days","volume":"83","author":"Lee","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.012_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(98)00099-7","article-title":"Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial","volume":"58","author":"Wong","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.012_bb0130","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12\u201320 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.012_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humrep\/den328","article-title":"Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial","volume":"24","author":"von Hertzen","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.012_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00404-007-0374-9","article-title":"Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol","volume":"276","author":"Yilmaz","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2011.03.012_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2007.09.007","article-title":"Second-trimester pregnancy termination with 600-mcg vs. 400-mcg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial","volume":"77","author":"Carbonell","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.012_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/13625180903417486","article-title":"Moistening of misoprostol tablets with acetic acid prior to vaginal administration for mid-trimester termination of anomalous pregnancy: a randomised comparison of three regimens","volume":"15","author":"Yilmaz","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.03.012_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006254-197802000-00001","article-title":"Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence","volume":"33","author":"Csapo","year":"1978","journal-title":"Obstet Gynecol Surv"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T20:23:12Z","timestamp":1543782192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0010782411001181"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.03.012","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}